If one cytoreductive surgery and HIPEC procedure for mesothelioma is good, subsequent treatments may be even better. That is the central message of research conducted at the Moffitt Cancer Center in Florida. The study’s aim was to assess overall survival among peritoneal mesothelioma patients who had not just one, but two or more rounds of heated intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The cytoreduction/HIPEC approach … Continue reading Repeat HIPEC Improves Mesothelioma Survival
New research conducted in Italy and presented at the 15th World Conference on Lung Cancer in Sydney, Australia suggests that mesothelioma surgery – no matter what kind – may not offer a survival advantage over medical management for the healthiest of patients. Mesothelioma is a rare but aggressive malignancy that is highly resistant to standard cancer treatments. The two types of mesothelioma surgery considered to … Continue reading Value of Mesothelioma Surgery Challenged for Healthy Patients
Cancer researchers at Wake Forest University have found another benefit to the cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) combination used to treat peritoneal mesothelioma and other abdominal cancers: the control of fluid buildup. Fluid accumulation in the abdomen because of peritoneal mesothelioma or another type of cancer is known as ascites. Left untreated, ascites can cause bloating, discomfort, disfiguration, and shortness of breath … Continue reading Mesothelioma Surgery May Have Added Benefit
A new analysis of pleurectomy/decortication suggests that the most radical form of the surgery produces the best results for mesothelioma patients, but also carries the greatest risk. Pleurectomy/decortication or P/D involves the removal of the pleural lining where malignant mesothelioma grows. Removing all or part of the lining frees up the lungs to expand again, relieving life-limited mesothelioma symptoms such as shortness of breath. But, as … Continue reading P/D for Mesothelioma: Are the Studies Accurate?
Peritoneal mesothelioma patients who have cytoreductive surgery (CRS) and heated chemotherapy can sometimes benefit from a second surgery, but it may be harder the second time around. Researchers in France have recently published their findings in a study of patients with mesothelioma and other peritoneal cancers who experienced recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Peritoneal mesothelioma is an asbestos-related malignancy that spreads … Continue reading Mesothelioma Study Cites Risks & Benefits of Second Surgery
Doctors in the Department of Respiratory medicine at York Teaching Hospital in the UK are taking a hard stance against the surgical treatment of malignant pleural mesothelioma. In a recent article in the journal Thorax, the group contends that the research surrounding mesothelioma surgery is largely flawed and that the majority of mesothelioma patients would be better served if their doctors suggested alternatives. “Belief that the … Continue reading Mesothelioma Report Suggests Clinical Trials Better Than Surgery
A distinguished group of experts in lung-sparingmesothelioma treatment techniques say there is more reason than ever for patients with this deadly cancer to be hopeful. Robert Cameron, MD, Director of the UCLA Mesothelioma Comprehensive Research Program and Chief of Thoracic Surgery at West Los Angeles VA Medical Center recently led the 3rd annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica. Hosted … Continue reading Mesothelioma Lung-Sparing Proponents Increase
A Chandler, Arizona man is recovering after becoming the second person in the world to undergo robotic surgery for mesothelioma. Carlos Tarazon, a 67-year-old former construction worker, was diagnosed with malignant pleural mesothelioma after spending more than 20 years in the construction industry. He had exhausted his treatment options when he was referred to University of Arizona Medical Center thoracic surgeon Farid Gharagozloo, MD, who elected … Continue reading Can Robotics Make Mesothelioma Surgery Safer?
Completeness of surgery, tumor grade, and the use of the chemotherapy drug cisplatin all have an impact on survival after peritoneal mesothelioma surgery and heated intraoperative chemotherapy, according to recent studies. Peritoneal mesothelioma is a cancer of the abdominal wall. This type of mesothelioma is often treated by surgery to remove as much of the cancer as possible (Cytoreductive surgery or CRS) followed by a wash of … Continue reading Studies Confirm Success Factors for Mesothelioma Surgery
Mesothelioma patients who undergo pleurectomy/decortication (P/D) may enjoy a better quality of life afterward than those who have extrapleural pneumonectomy (EPP). That is the message of a new study published in the Asian Cardiovascular and Thoracic Annals. Pleural mesothelioma arises most often in the thin lining that surrounds the lungs. Because of its close proximity to the lungs, it is not uncommon for pleural mesothelioma to … Continue reading Better Quality of Life from Lung-Sparing Mesothelioma Surgery
Get your free copy of
“Surviving Mesothelioma” Today!